FDA Classifies Plazomicin Test System into Class II Special Controls

Summary

The FDA has classified the plazomicin test system into Class II special controls, aiming to provide a reasonable assurance of safety and effectiveness while reducing regulatory burdens and enhancing patients' access to innovative devices.